Annual General Meeting
-
Annual General Meeting 2024
-
Documents
06/28/2024
INFORMATION IN ACCORDANCE WITH TABLE 8 OF THE REGULATION (EU) 2018/1212
06/28/2024
06/28/2024
05/28/2024
05/27/2024
STATEMENT ON THE COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT
05/27/2024
05/27/2024
EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2024 (GERMAN)
05/27/2024
INFORMATION PURSUANT TO TABLE 3 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212 (GERMAN)
05/27/2024
COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT
05/16/2024
05/16/2024
REPORT OF THE SUPERVISORY BOARD FOR THE 2023 FINANCIAL YEAR (GERMAN)
05/16/2024
ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)
05/16/2024
-
-
Voting results
28.06.2024
DIVIDEND ANNOUNCEMENT (GERMAN)
28.06.2024
VOTING RESULTS AGM 2024 (GERMAN)
-
-
Annual General Meeting 2023
-
Documents
06/14/2023
20230614 CN DERMAPHARM AGM 2023
05/08/2023
ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)
03/28/2023
DERMAPHARM ANNUAL FINANCIAL STATEMENT 2022
03/28/2023
05/08/2023
EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2023 (GERMAN)
05/11/2023
INFORMATION PURSUANT TO TABLE 3 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212 (GERMAN)
05/08/2023
INFORMATION PURSUANT TO TABLE 8 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212
05/08/2023
05/08/2023
05/08/2023
REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023 (GERMAN)
-
-
-
-
Annual General Meeting 2022
-
Documents
INFORMATION PURSUANT TO TABLE 8 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212
DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2021
INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2021
REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2021 (GERMAN)
-
-
-
-
Annual General Meeting 2021
-
Documents
DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2020
INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2020
REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2020 (GERMAN)
-
-
-
-
Annual General Meeting 2020
-
Documents
DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2019
INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2019
REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2019 (GERMAN)
-
-
-
-
Annual General Meeting 2019
-
Documents
DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2018
INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2018
REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2018
-
-
-
-